リガンド機能化されたDNAナノ構造と細胞の相互作用の決定因子

Glenn A O Cremers^1,2, Bas J H M Rosier^1,2, Ab Meijs^1,2,3

¹Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, 5600 MB Eindhoven, The Netherlands.

Journal of the American Chemical Society

|June 28, 2021

まとめ

抗体で機能するDNAナノ構造は標的の薬物投与を提供しますナノ構造のサイズとDNAハンドルの位置は,細胞表面受容体への結合効率に大きく影響し,最適なナノ医療設計を導く.

科学分野:

バイオテクノロジー
ナノテクノロジー
分子生物学

背景:

リガンド機能化されたナノマテリアルは,標的型ナノ医薬品にとって極めて重要です.
DNAナノテクノロジーは,制御されたリガンドの組み込みのためのナノ構造の正確な構築を可能にします.
細胞表面受容体を効果的に標的にするには,細胞アクセシビリティを理解することが重要です.

研究の目的:

抗体機能化されたDNAナノ構造の細胞表面受容体への結合に影響を与える設計パラメータを調査する.
受容体のアクセシビリティと結合効率を調節する構造的決定因子を特定する.
DNAナノ構造で細胞標的を最適化するための設計ルールを確立する.

主な方法:

抗体機能化されたDNAナノ構造の体系的な調査.
特定の受容体への結合の評価:プログラム細胞死タンパク質1 (PD-1),表皮成長因子受容体 (EGFR),およびヒト表皮成長因子受容体2 (HER2).
重要な設計パラメータとして,ナノ構造のサイズとDNAハンドルの位置の分析.

主要な成果:

ネイティブ抗体の親和性は変わらないが,アクセシビリティの制限により,溶解性抗体と比較して全体的な受容体結合は減少している.
ナノ構造のサイズとDNAハンドルの位置は,受容体結合効率を決定する.
ナノ構造構造の影響を強調し,受容体結合機構の洞察を得ました.

結論:

抗体機能化されたDNAナノ構造は細胞表面受容体と結合できますが,効率はアクセシビリティによって影響されます.
ナノ構造のサイズとDNAハンドルの位置は細胞標的を最適化するための重要な設計要因です
この研究は,ナノ医療のための効果的なリガンド機能化されたDNAナノ構造を開発するための重要な設計規則を提供します.

さらに関連する動画

08:59

DNA Origami-Mediated Substrate Nanopatterning of Inorganic Structures for Sensing Applications

Published on: September 27, 2019

11.8K

06:53

DNA Tension Probes to Map the Transient Piconewton Receptor Forces by Immune Cells

Published on: March 20, 2021

2.9K

関連する概念動画

02:40

Ligand Binding Sites

14.3K

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

14.3K

02:51

Metal-Ligand Bonds

22.5K

The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...

22.5K

01:25

Drug-Receptor Bonds

3.7K

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...

3.7K

03:31

Labeling DNA Probes

8.6K

DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...

8.6K

00:49

Ligand Binding and Linkage

5.1K

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...